Fortive Corp. 10-Q Summary: Q1 2026
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended April 3, 2026. Fortive Corporation operates two strategic segments: Intelligent Operating Solutions (IOS) and Advanced Healthcare Solutions (AHS). The company completed the separation of its former Precision Technologies segment (now Ralliant Corporation) on June 28, 2025; results for this business are reported as discontinued operations. The filing reflects continuing operations only, unless otherwise noted.
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Total Sales | $1,069.4 million | $993.1 million |
| Gross Profit | $675.5 million | $637.5 million |
| Operating Profit | $191.7 million | $165.3 million |
| Net Earnings (Continuing Ops) | $136.4 million | $112.6 million |
| Diluted EPS (Continuing Ops) | $0.44 | $0.33 |
| Operating Cash Flow (Continuing Ops) | $220.4 million | $191.8 million |
| Cash and Equivalents (Ending) | $356.1 million | $892.1 million |
| Total Debt (Carrying Value) | $3,489.1 million | $3,206.0 million |
Material Changes vs. Prior Period
- Revenue Growth: Total sales increased 7.7% year-over-year. Core revenue (excluding acquisitions/divestitures and currency) grew 5.3%, driven by favorable pricing (2.2%) and volume growth (3.1%).
- Margin Expansion: Operating profit margin improved to 17.9% from 16.6% in the prior year, a 130 basis point increase. This was driven by pricing, volume, and productivity initiatives, partially offset by higher compensation and tariff impacts.
- Segment Performance:
- IOS: Sales rose 7.6% to $743.2 million; operating profit margin decreased slightly by 20 basis points to 25.1%.
- AHS: Sales rose 7.9% to $326.2 million; operating profit margin expanded significantly by 280 basis points to 10.0%.
- Capital Allocation: The company repurchased 8.9 million shares for approximately $500.2 million, compared to 2.5 million shares for $202.6 million in the prior year. Dividends paid were $18.4 million.
- Debt Management: Fortive repaid $292.9 million of 3.7% Euro-denominated notes due in 2026, utilizing proceeds from commercial paper borrowings. Commercial paper borrowings increased to $1,241.1 million.
Outlook, Risks, and Management Commentary
- Guidance: The filing does not provide specific numerical guidance for the full year 2026. Management notes that results for the quarter are not necessarily indicative of full-year results.
- Market Risks: Key risks include geopolitical conflicts (Middle East, Ukraine), trade policy volatility (tariffs), foreign currency fluctuations, and supply chain disruptions. Management is actively deploying the Fortive Business System (FBS) to manage costs and optimize logistics.
- Restructuring: A restructuring plan initiated in late 2024 is ongoing, with charges of $6.3 million incurred in Q1 2026. The plan is expected to be completed by the second half of 2026.
- Liquidity: The company maintains a $2.0 billion revolving credit facility (extended to 2031) with no outstanding borrowings as of April 3, 2026. Management expects sufficient liquidity to meet obligations and fund strategic initiatives.
Investor Verification Checklist
- Verify the impact of the Precision Technologies separation on future comparability, noting that Q1 2025 included discontinued operations earnings of $59.3 million which are absent in Q1 2026.
- Monitor the commercial paper program levels ($1.24 billion) and the reliance on short-term debt to refinance maturing long-term notes.
- Assess the sustainability of margin expansion in the AHS segment (280 bps increase) versus the slight contraction in IOS, considering tariff headwinds and compensation costs.
- Review the share repurchase authorization remaining ($67.5 million under the Special Program and 6.6 million shares under the General Program) to gauge future capital return capacity.
- Track foreign currency translation impacts, which negatively affected revenue growth by 2.4% in the quarter.